Google Chrome
Safari
Firefox
Edge
Search
Dispersome®
Make your drug soluble with Dispersome® technology. Dispersome® is a solubility enhancement technology that relies on an innovative and naturally occurring excipient to develop amorphous solid dispersions with high drug loading and high bioavailability.
Press Release / Jun 18, 2024
Hovione Unveils New Continuous Tableting Line at Lisbon R&D Centre
Hovione is proud to announce the opening of a state-of-the-art continuous tableting (CT) line at its R&D Center in Lisbon.
Press Clipping / Mar 19, 2020
Stepping up to the hand sanitizer shortage
Chemical companies, breweries, and perfumeries take to making and donating a vital commodity in short supply
Press Clipping / Apr 06, 2023
Hovione 2023 CDMO Leadership Awards Winner Interview
Outsourced Pharma, April 2023
News / Apr 29, 2025
Widespread power outage in Portugal - Message to our clients
News release, 29 April 2025
Continuous Flow
Expand the established chemistry space with Continuous Flow to deliver robust and sustainable processes.
Press Release / Aug 23, 2022
Zerion Pharma and Hovione extend partnership to cover use of the Dispersome® technology platform in nutraceuticals
Hovione today announced an extension of collaboration on Zerion’s Dispersome® technology into the nutraceutical/dietary supplements field.
Press Clipping / Oct 27, 2025
Hovione Completes Initial $100M Investment Cycle to Expand U.S. Operations at New Jersey Manufacturing Site
Innovations in Pharmaceutical Technology, IPT Online, 27 October 2025